Steve Kemp Email & Phone Number

London, Florida, Boston, New York City

ID Funds, LLC is a by-invitation only private equity investment company. ID Fund's investors include high net worth accredited and qualified individuals, family offices, institutions and non-U.S. investors. ID Fund seeks investments in high quality late state companies with imminent exit opportunities (sale or IPO) which is expected within 18-24 months. ID Fund partners with companies in two ways: it offers flexibility to lead or participate in raising new private financing's and provides liquidity to founders, early stage investors, or angel investors that might want immediate liquidity. ID Fund provides clients with professionalism, certainty, speed and execution.

Bedford, United Kingdon

Appointed to oversee all commercial aspects of operations, including strategy, goal-setting, business development, marketing, strategic partnerships, M&A and key customer relationships across the pharmaceutical, healthcare, medical devices and veterinary markets served by Central Pharma. Spearhead the company’s expansion into new markets to achieve growth targets and ensure processes compatible with World Class Excellence are implemented.

London, United Kingdom

Power Wood is a company investing, developing, deploying technology and producing sustainable power and renewable energy from waste woody Biomass in Europe and Canada with each power station producing circa 41.5MW.As Chief Executive Officer, I oversee all aspects of the venture, including financing, contracts and project management.

Calgary, Alberta, Canada

Alternative and renewable sources of energy are vital for sustainable development globally. PowerWood develops projects that provide a sustainable source of energy for everyday living and the manufacture of products that improve living standards the world over. PowerWood Canada Corporation is currently developing a sustainable energy plant in Northern Alberta, where sawmill waste and deciduous timber from managed forests will be used to generate 41.5MWe base load power for the Alberta grid. The project will be a major part of Alberta’s drive for renewable energy.

Hereford, United Kingdom

Provided strategic consultancy which delivered business growth, shareholder value and achieved the objective of sale of the business in 2016.

Nottingham Uk

Executive Board position, NASDAQ listed company with P&L responsibility and accountability for Quality, Operations, Facilities, Commercial Services, Sales and Marketing.Appointed to lead growth and development of the then privately owned company in readiness for shareholder sale. Sale completed Sept 2013 to Columbia Laboratories, a public listed company. Doubled revenues in first year, then again in year 2, led CAPEX of more than £1.5m after moving into purpose built facilities and clean rooms, laboratories for pharmaceutical and formulation development services, material characterisation, enabling technologies, early phase clinical trial manufacture and packaging.Achievements• Marketing and PR development to increase awareness and visibility, European and US wide• Preparation and selection of Enterprise system for finance, projects, purchasing, quality• Opened new production capability and MHRA approval of new facility• Facility compliance• CAPEX of £500k year 1 and CAPEX of £1.5m year 2• Instrumental in achieving double growth year 1 and year 2

Vienna, Vienna, Austria

The goal of HCPC Europe is to achieve demonstrable improvement in patient compliance through the implementation of packaging-related initiatives, including:• Promoting an understanding of the importance of patient compliance• Curating information about patient compliance, particularly as it relates to packaging• Supporting research into packaging-related proposals to improve patient compliance• Formulating recommendations for packaging solutions most likely to enhance patient compliance• Sharing knowledge with government bodies, industry, healthcare professionals and the public• Collaborating with other industry organisations for mutual benefit

Vienna, Vienna, Austria

The goal of HCPC Europe is to achieve demonstrable improvement in patient compliance through the implementation of packaging-related initiatives.

Hay-On-Wye, Herefordshire

I joined Brecon Pharmaceuticals in 2001with a brief to deliver a strategy and five-year plan in preparation for shareholder sale. Revenue increased sixfold and profit by 1300% ahead of the company's sale to AmerisourceBergen – one of the largest global pharmaceutical sourcing and distribution services companies – in March 2006. Responsibilities include providing vision, generating strategy, sales, marketing and PR, developing annual budget, identifying acquisitions and revenue streams, actively promoting strategic relationships at Board level with key customers and ensuring relevant resources are in place to support on coming business.Achievements• Instrumental in achieving growth from £2.4m to £25m to date as a stand alone company, merged and rebranded with Anderson in 2012 to become $230 million group (AndersonBrecon)• Marketing and PR development to increase company visibility• Drove CAPEX to increase capacity for new revenue streams• Strategic Japanese packing work for top pharma company, six-year project @ £6m per annum• Largest phase III study for large pharma outsourced to Brecon• Introduced primary and secondary specialty pharma centre

UK office, outsource services provider to the Pharmaceutical Sector. Prior to that known as PCI / Unipack